Prasad replaces Dr. Peter Marks, who served as the director of the Center for Biologics Evaluation and Research at the FDA and played a key role in launching Operation Warp Speed — the Trump ...

Geoff Bennett discussed the treatment and its potential with Dr. Peter Marks. He oversaw gene therapy treatment and vaccine safety and approval for the FDA before he left in March. Let's turn now ...

In the wake of the high-profile departure of Peter Marks, M.D., Ph.D., the FDA has a new leader for its Center for Biologics Evaluation and Research (CBER). FDA Commissioner Marty Makary ...

Geoff Bennett discussed the treatment and its potential with Dr. Peter Marks. He oversaw gene therapy treatment and vaccine safety and approval for the FDA before he left in March. PBS News Hour ...

Peter Stewart at Horace Mann and Dave Chilson at Roosevelt are both retiring. We sat down with Stewart to reflect on what he ...

Prasad replaces Peter Marks, the longtime leader of the Center for Biologics Evaluation and Research (CBER), who resigned in March after clashing with Health and Human Services (HHS) Secretary ...

Last year, he accused his predecessor as the head of the CBER, Peter Marks, of being "either incompetent or corrupt" for allowing the approvals. More recently, Prasad has heaped praise on new FDA ...

In late March, Dr. Peter Marks, the Food and Drug Administration’s top vaccine official, was forced out of his job by Health Secretary Robert F. Kennedy Jr. In a resignation letter, Marks wrote ...

The move comes after the March resignation of former CBER director Peter Marks, MD, PhD. In his resignation letter, Dr. Marks cited HHS Secretary Robert F. Kennedy Jr.’s views on vaccinations as ...

REUTERS/Andrew Kelly/File Photo In March, Peter Marks, the FDA’s former head of the division, which regulates vaccines and biologics, was pushed out of the agency. Scott Steele, an FDA insider ...

He replaces Dr. Peter Marks, who helped lead the division for 13 years and shaped the Operation Warp Speed effort to rapidly develop Covid-19 vaccines and treatments. “It has become clear that ...

Prasad succeeds Peter Marks, a widely respected expert who resigned from the FDA in March after clashing with Kennedy. “I was willing to work to address [Kennedy’s] concerns regarding vaccine ...